In summary, the overwhelming evidence suggesting a crucial role for c-MYC in liver disease warrants further investigation utilizing transgenic mice models in combination with hepatotoxins, may lead to the discovery of novel functions of this ubiquitous transcription factor, and to novel therapeutic strategies for a broad range of hepatic injuries. The gene discussed is MYC; the disease is liver disorder.